Watch: Private Hospitals in India Making Profits up to 1737%
A study by the drug price regulator has said that major beneficiaries of profits from inflated prices have been hospitals, not patients or manufacturers.
Advertisement
Real journalism holds power accountable
Since 2015, The Wire has done just that.
But we can continue only with your support.
A study by the drug price regulator has said that major beneficiaries of profits from inflated prices have been hospitals, not patients or manufacturers.
This article went live on February twenty-fourth, two thousand eighteen, at thirty minutes past four in the afternoon.The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.
Advertisement
Make a contribution to Independent Journalism
Advertisement